Phase 1 Trials Shows Plant-Produced Cancer Vaccine as Safe
Filed in archive Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics on July 28, 2008
Phase 1 trials of the the first human tests of a vaccine grown in tobacco plants proved that the vaccine against against follicular B-cell lymphoma were safe for patients. If further trials demonstrate its efficacy, this presents a novel method of producing vaccines quickly and cheaply.
The researchers chose tobacco plants that were genetically modified to reproduce quantities of the vaccine. To make a tobacco plant churn out a human antibody, scientists isolate the antibody from the patient's tumor and put the antibody gene into a modified version of the tobacco mosaic virus. They infect a tobacco plant with the gene-carrying virus by scratching the virus on its leaves. The virus takes the gene into the plant's cells, which then churn out lots of antibody. After a few days, technicians snip off the plant's leaves, grind them up and purify the antibody. Only a few plants are needed to make enough vaccine for each patient.
"The new manufacturing system allows very rapid production of a vaccine," said Charles Arntzen, PhD, a professor of plant biology at the Arizona Biodesign Institute at Arizona State University, who was not involved in the research. "I think without the speed, it would be hard to convince a cancer patient to wait for a vaccine to be developed, rather than going on some other therapy."
The study is published in the advance online issue of the Proceedings of the National Academy of Science.
"The new manufacturing system allows very rapid production of a vaccine," said Charles Arntzen, PhD, a professor of plant biology at the Arizona Biodesign Institute at Arizona State University, who was not involved in the research. "I think without the speed, it would be hard to convince a cancer patient to wait for a vaccine to be developed, rather than going on some other therapy."
Tags: genetics GMO vaccine cancer lymphoma Hodgkins trials phase+trials
Vote for Phase 1 Trials Shows Plant-Produced Cancer Vaccine as Safe:
|
Rating: 9.33 out of 3 vote(s) cast.
|
Response from:
rapid
Bookmarked your post over at Blog Bookmarker.com!
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells

